Shandong Net Receivables from 2010 to 2025
| 600529 Stock | 24.60 0.41 1.64% |
Net Receivables | First Reported 2000-12-31 | Previous Quarter 971.3 M | Current Value 987.8 M | Quarterly Volatility 331.3 M |
Check Shandong Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 512.3 K, Selling General Administrative of 177.4 M or Total Revenue of 6 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Pharmaceutical Valuation or Volatility modules.
Shandong | Net Receivables |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.